Compare Teucrium Soybean Fund (SOYB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teucrium Soybean Fund vs State Street SPDR S&P Biotech ETF — how do they compare? Teucrium Soybean Fund trades at $25.86, while State Street SPDR S&P Biotech ETF trades at $154.4. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| SOYB | XBI | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $25.88 | $164.28 |
52-Week Low | $21.07 | $85.16 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOYB is trading at $25.88, up 1.53% today with strong technical momentum as moving averages signal bullish sentiment. The stock shows mixed oscillator readings with RSI suggesting potential overbought conditions. Recent agricultural sector news highlights potential tailwinds from China's $17 billion crop purchase commitment through 2028, which could benefit agricultural companies.
The stock presents bullish technical positioning but requires fundamental validation through upcoming earnings reports. Key risks include commodity price volatility and execution challenges. Upside potential exists if the company can capitalize on agricultural export opportunities, though investors should await financial metric updates for proper valuation assessment.
XBI, the SPDR S&P Biotech ETF, trades at $150.94, down 2.14% today amid a bearish technical signal. The ETF holds 155 biotech stocks equally weighted, offering high beta exposure. Recent news highlights a 17% monthly surge driven by AI drug discovery and M&A activity, though analyst consensus remains a lone Hold rating. Key support sits at $151 with resistance at $155.
Outlook hinges on biotech sector momentum from innovation and deal flow, but risks include volatility from small-cap holdings and regulatory uncertainty. The neutral sentiment and lack of fundamental ratios suggest investors await clearer earnings trends from underlying holdings for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
